2022 Q4 Form 10-K Financial Statement

#000156459023005061 Filed on March 31, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022 2021
Revenue $12.29M $52.17M $53.48M
YoY Change -3.89% -2.44% 4.41%
Cost Of Revenue $5.671M $20.46M $20.34M
YoY Change 6.22% 0.58% -2.61%
Gross Profit $6.621M $31.71M $33.13M
YoY Change -11.14% -4.3% 9.24%
Gross Profit Margin 53.86% 60.78% 61.96%
Selling, General & Admin $5.735M $23.30M $24.19M
YoY Change 2.34% -3.68% -21.45%
% of Gross Profit 86.62% 73.5% 73.02%
Research & Development $3.840M $14.36M $16.11M
YoY Change 36.03% -10.9% -23.28%
% of Gross Profit 58.0% 45.27% 48.63%
Depreciation & Amortization $531.0K $2.124M $1.200M
YoY Change -53.99% 77.0% -25.0%
% of Gross Profit 8.02% 6.7% 3.62%
Operating Expenses $10.11M $39.78M $16.11M
YoY Change 9.85% 146.92% -23.28%
Operating Profit -$3.485M -$8.075M $17.02M
YoY Change 99.26% -147.44% -138.63%
Interest Expense $55.00K $88.00K $37.00K
YoY Change 1733.33% 137.84% 23.33%
% of Operating Profit 0.22%
Other Income/Expense, Net -$2.000K -$11.00K $2.487M
YoY Change -33.33% -100.44%
Pretax Income -$3.467M -$8.061M -$4.158M
YoY Change 93.9% 93.87% -90.54%
Income Tax $107.0K $184.0K $232.0K
% Of Pretax Income
Net Earnings -$3.574M -$8.245M -$4.390M
YoY Change 75.63% 87.81% -88.58%
Net Earnings / Revenue -29.08% -15.8% -8.21%
Basic Earnings Per Share -$0.19 -$0.10
Diluted Earnings Per Share -$0.08 -$0.19 -$99.96K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q4 2022 2021
SHORT-TERM ASSETS
Cash & Short-Term Investments $20.47M $20.47M $27.09M
YoY Change -24.41% -24.41% -20.1%
Cash & Equivalents $20.47M $20.47M $27.09M
Short-Term Investments
Other Short-Term Assets $2.015M $2.015M $2.407M
YoY Change -16.29% -16.29% 9.41%
Inventory
Prepaid Expenses
Receivables $8.396M $8.396M $8.021M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $30.89M $30.89M $37.51M
YoY Change -17.67% -17.67% -11.31%
LONG-TERM ASSETS
Property, Plant & Equipment $4.788M $4.788M $5.055M
YoY Change 69.97% -5.28% -22.23%
Goodwill $17.60M
YoY Change 0.24%
Intangibles $2.590M
YoY Change -45.06%
Long-Term Investments
YoY Change
Other Assets $973.0K $973.0K $986.0K
YoY Change -1.32% -1.32% -24.15%
Total Long-Term Assets $25.91M $25.91M $28.31M
YoY Change -8.49% -8.49% -18.17%
TOTAL ASSETS
Total Short-Term Assets $30.89M $30.89M $37.51M
Total Long-Term Assets $25.91M $25.91M $28.31M
Total Assets $56.79M $56.79M $65.83M
YoY Change -13.72% -13.72% -14.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.037M $2.037M $1.363M
YoY Change 49.45% 49.45% -43.21%
Accrued Expenses $8.643M $8.643M $9.294M
YoY Change -7.0% -7.0% -22.55%
Deferred Revenue $1.384M
YoY Change -31.35%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change -100.0%
Total Short-Term Liabilities $12.06M $12.06M $12.67M
YoY Change -4.81% -4.81% -39.65%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $385.0K $385.0K $1.466M
YoY Change -73.74% -73.74% -52.71%
Total Long-Term Liabilities $385.0K $385.0K $1.466M
YoY Change -73.74% -73.74% -52.71%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.06M $12.06M $12.67M
Total Long-Term Liabilities $385.0K $385.0K $1.466M
Total Liabilities $12.68M $12.68M $14.33M
YoY Change -11.47% -11.47% -40.81%
SHAREHOLDERS EQUITY
Retained Earnings -$311.3M
YoY Change 2.72%
Common Stock $355.0M
YoY Change 0.24%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $44.11M $44.11M $51.50M
YoY Change
Total Liabilities & Shareholders Equity $56.79M $56.79M $65.83M
YoY Change -13.72% -13.72% -14.4%

Cashflow Statement

Concept 2022 Q4 2022 2021
OPERATING ACTIVITIES
Net Income -$3.574M -$8.245M -$4.390M
YoY Change 75.63% 87.81% -88.58%
Depreciation, Depletion And Amortization $531.0K $2.124M $1.200M
YoY Change -53.99% 77.0% -25.0%
Cash From Operating Activities -$501.0K -$2.292M -$6.342M
YoY Change -4.39% -63.86% 88.02%
INVESTING ACTIVITIES
Capital Expenditures $869.0K $2.865M $1.351M
YoY Change -294.41% 112.07% -0.15%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $400.0K
YoY Change -100.0% -82.91%
Cash From Investing Activities -$869.0K -$2.865M -$951.0K
YoY Change 94.41% 201.26% -196.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.485M -1.455M 528.0K
YoY Change -638.04% -375.57% -109.62%
NET CHANGE
Cash From Operating Activities -501.0K -2.292M -6.342M
Cash From Investing Activities -869.0K -2.865M -951.0K
Cash From Financing Activities -1.485M -1.455M 528.0K
Net Change In Cash -2.855M -6.612M -6.765M
YoY Change 310.79% -2.26% -14.15%
FREE CASH FLOW
Cash From Operating Activities -$501.0K -$2.292M -$6.342M
Capital Expenditures $869.0K $2.865M $1.351M
Free Cash Flow -$1.370M -$5.157M -$7.693M
YoY Change 1679.22% -32.97% 62.78%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4714000
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
13549000
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
35-2194038
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 2000
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Seattle
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98101
CY2022 dei Trading Symbol
TradingSymbol
MCHX
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2124000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-6000
CY2022 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
40000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1455000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6612000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
27086000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
27086000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
2155000
CY2021 us-gaap Profit Loss
ProfitLoss
-4390000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5970000
CY2022 mchx Allowance For Doubtful Accounts And Advertiser Credits
AllowanceForDoubtfulAccountsAndAdvertiserCredits
906000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
43000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
2646000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2125000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-647000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1050000
CY2021 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-3876000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2292000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2865000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14355000
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001224133
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2022#ServiceMember
CY2022 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2022#ServiceMember
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y5M15D
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y8M1D
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y
CY2022 dei Entity Registrant Name
EntityRegistrantName
Marchex, Inc.
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
520 Pike Street
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
CY2022 dei City Area Code
CityAreaCode
206
CY2022 dei Local Phone Number
LocalPhoneNumber
331-3300
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
46156094
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27086000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20474000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8021000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8396000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2407000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2015000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
37514000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
30885000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2817000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4050000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
986000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
973000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2238000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
738000
CY2021Q4 us-gaap Goodwill
Goodwill
17558000
CY2022Q4 us-gaap Goodwill
Goodwill
17558000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2590000
CY2021Q4 us-gaap Assets
Assets
65827000
CY2022Q4 us-gaap Assets
Assets
56794000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1363000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2037000
CY2021Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
3631000
CY2022Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
3566000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3869000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3825000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2016000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1384000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1794000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1252000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12673000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12064000
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
186000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
233000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1466000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
385000
CY2021Q4 us-gaap Liabilities
Liabilities
14325000
CY2022Q4 us-gaap Liabilities
Liabilities
12682000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
137500000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
137500000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
354155000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
354999000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-303076000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-311321000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
51502000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
44112000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
65827000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
56794000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
53476000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
52170000
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
21694000
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
20462000
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
13517000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16112000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9294000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9787000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4481000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2124000
CY2021 mchx Business Combination Acquisition And Disposition Related Cost Benefit
BusinessCombinationAcquisitionAndDispositionRelatedCostBenefit
142000
CY2022 mchx Business Combination Acquisition And Disposition Related Cost Benefit
BusinessCombinationAcquisitionAndDispositionRelatedCostBenefit
74000
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
65272000
CY2022 us-gaap Costs And Expenses
CostsAndExpenses
60319000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-11796000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-8149000
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
5185000
CY2021 mchx Interest Income And Other Net
InterestIncomeAndOtherNet
2453000
CY2022 mchx Interest Income And Other Net
InterestIncomeAndOtherNet
88000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4158000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8061000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
232000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
184000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4390000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8245000
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.19
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.19
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4481000
CY2021 us-gaap Interest Income Related Party
InterestIncomeRelatedParty
6607000
CY2022 us-gaap Interest Income Related Party
InterestIncomeRelatedParty
6398000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
52688000
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
530000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2674000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-4390000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
51502000
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
39000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2646000
CY2022 mchx Adjustments To Additional Paid In Capital Settlement Of Contractual Obligation
AdjustmentsToAdditionalPaidInCapitalSettlementOfContractualObligation
1830000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-8245000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
44112000
CY2022 us-gaap Profit Loss
ProfitLoss
-8245000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4033000
CY2021 mchx Allowance For Doubtful Accounts And Advertiser Credits
AllowanceForDoubtfulAccountsAndAdvertiserCredits
435000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
2674000
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
5185000
CY2021 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
59000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1280000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-73000
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
675000
CY2022 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-510000
CY2021 mchx Increase Decrease In Contract With Customer Liability And Deposits
IncreaseDecreaseInContractWithCustomerLiabilityAndDeposits
623000
CY2022 mchx Increase Decrease In Contract With Customer Liability And Deposits
IncreaseDecreaseInContractWithCustomerLiabilityAndDeposits
-633000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6342000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1351000
CY2021 us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
400000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-951000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2865000
CY2022 mchx Settlement Of Contractual Obligation
SettlementOfContractualObligation
1495000
CY2021 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
528000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
528000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6765000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
33851000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
20474000
CY2021 mchx Foreign Government Paycheck Assistance And Rent Subsidies
ForeignGovernmentPaycheckAssistanceAndRentSubsidies
444000
CY2022 mchx Foreign Government Paycheck Assistance And Rent Subsidies
ForeignGovernmentPaycheckAssistanceAndRentSubsidies
10000
CY2021 mchx Settlement Of Contract Matter
SettlementOfContractMatter
2500000
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
1648000
CY2021 mchx Cares Act Loan Extinguishment
CARESActLoanExtinguishment
5119000
CY2022 mchx Settlement Of Contractual Obligation Non Cash Financing Activities
SettlementOfContractualObligationNonCashFinancingActivities
335000
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-174000
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-55000
CY2022 us-gaap Basis Of Accounting
BasisOfAccounting
<p style="margin-top:2pt;line-height:11pt;margin-bottom:0pt;margin-left:1.89%;text-indent:1.89%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Basis of Presentation</p> <p style="line-height:11pt;margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-size:6pt;"> </p> <p style="line-height:11pt;margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP"). <span style="color:#000000;">The preparation of our Consolidated Financial Statements requires management to make estimates and assumptions that affect the amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period, including the effects of COVID-19. The Company has used estimates related to several financial statement amounts, including revenues, allowance for doubtful accounts, allowance for advertiser credits, useful lives for property and equipment and intangible assets, valuation of intangible assets, the fair value of stock options awards, the impairment of goodwill, and the valuation allowance for deferred tax assets. Actual results could differ from those estimates.</span></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our Company consolidates all entities that we control by ownership of a majority voting interest. All inter-company transactions and balances have been eliminated in consolidation. Certain reclassifications have been made to the Consolidated Financial Statements in the prior periods to conform to the current period presentation.</p> <p style="line-height:11pt;margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-size:6pt;"> </p> <p style="margin-bottom:6pt;margin-top:0pt;text-indent:3.78%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additionally, there are situations in which U.S. GAAP requires consolidation even though the usual condition of consolidation (ownership of a majority voting interest) does not apply. Generally, this occurs when an entity holds an interest in another business enterprise that was achieved through arrangements that do not involve voting interests, which results in a disproportionate relationship between such entity's voting interests in, and its exposure to the economic risks and potential rewards of, the other business enterprise. This disproportionate relationship results in what is known as a variable interest, and the entity in which we have the variable interest is referred to as a "VIE." An enterprise must consolidate a VIE if it is determined to be the primary beneficiary of the VIE. The primary beneficiary has both (1) the power to direct the activities of the VIE that most significantly impact the entity's economic performance and (2) the obligation to absorb losses or the right to receive benefits from the VIE that could potentially be significant to the VIE.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We held a remaining interest in the related party purchaser of our divested operations until we disposed of our interest in the third quarter of 2021. We determined during the period of holding an interest <span style="color:#000000;">we were not the primary beneficiary. Our variable interests in this VIE primarily relate to the issuance of </span><span style="Background-color:#FFFFFF;color:#000000;">a 10% equity interest in the related party purchaser; </span><span style="Background-color:#FFFFFF;color:#000000;">contingent consideration related to the transaction;</span><span style="color:#000000;"> and an administrative support services arrangement. Refer to Note 10: Divestiture Support Services Agreement. Although this financial arrangement resulted in our holding variable interests in this related party entity, it did not empower us to direct the strategic and operational activities of the VIE that most significantly impact the VIE’s economic performance. Our Company's investment related to this VIE totaled $341,000 as of December 31, 2020, representing our maximum exposure to </span></p> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;">loss. In the third quarter of 2021, we sold our equity interest for proceeds of $</span><span style="color:#000000;">400,000</span><span style="color:#000000;">. The Company's investment related to this VIE was not individually significant to the Company's Consolidated Financial Statements.</span></p>
CY2022 us-gaap Variable Interest Entity Ownership Percentage
VariableInterestEntityOwnershipPercentage
0.10
CY2020Q4 mchx Variable Interest Entity Equity Investments Funded Maximum Exposure To Loss
VariableInterestEntityEquityInvestmentsFundedMaximumExposureToLoss
341000000
CY2021Q3 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
400000000
CY2022 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P3Y
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1000000.0
CY2022Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1400000
CY2021Q4 us-gaap Goodwill
Goodwill
17600000
CY2022Q4 us-gaap Goodwill
Goodwill
17600000
CY2021Q4 mchx Allowance For Advertiser Credits
AllowanceForAdvertiserCredits
157000
CY2022Q4 mchx Allowance For Advertiser Credits
AllowanceForAdvertiserCredits
84000
CY2021Q4 us-gaap Deferred Revenue
DeferredRevenue
2000000.0
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
1400000
CY2021 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1400000
CY2022 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1100000
CY2022 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Explanation
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation
The majority of the Company’s total revenue is derived from contracts that include consideration that is variable in nature. The variable elements of these contracts primarily include the number of transactions (for example, the number qualified phone calls). For contracts with an effective term greater than one year, the Company applies the standard’s practical expedient that permits the exclusion of disclosure of the value of unsatisfied performance obligations for these contracts as the Company’s right to consideration corresponds directly to the value provided to the customer for services completed to date and all future variable consideration is allocated to wholly unsatisfied performance obligations. A term for purposes of these contracts has been estimated at 24 months. In addition, the Company applies the standard’s optional exemption to disclose information about performance obligations for contracts that have original expected terms of one year or less
CY2021 us-gaap Advertising Expense
AdvertisingExpense
1400000
CY2022 us-gaap Advertising Expense
AdvertisingExpense
928000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
19628000
CY2022Q4 mchx Number Of Financial Institutions
NumberOfFinancialInstitutions
2
CY2022 us-gaap Guarantees Indemnifications And Warranties Policies
GuaranteesIndemnificationsAndWarrantiesPolicies
<p style="margin-top:12pt;margin-bottom:0pt;margin-left:1.89%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">(p) Guarantees</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">FASB ASC Topic 460, <span style="font-style:italic;">Guarantees </span>provides accounting guidance surrounding liability recognition and disclosure requirements related to guarantees. In the ordinary course of business, the Company is not subject to potential obligations under guarantees that fall within the scope of FASB ASC Topic 460 except for standard indemnification provisions that are contained within many of the Company’s agreements, and give rise only to the disclosure requirements prescribed by FASB ASC Topic 460.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In certain agreements, the Company has agreed to indemnification provisions of varying scope and terms with customers, vendors and other parties with respect to certain matters, including, but not limited to, losses arising out of the Company’s breach of agreements or representations and warranties made by the Company, services to be provided by the Company and intellectual property infringement claims made by third parties. As a result of these provisions, the Company may from time to time provide certain levels of financial support to contract parties to seek to minimize the impact of any associated litigation in which they may be involved. To date, there have been no known events or circumstances that have resulted in any material costs related to these indemnification provisions and no liabilities therefore have been recorded in the accompanying Consolidated Financial Statements. However, the maximum potential amount of the future payments the Company could be required to make under these indemnification provisions could be material.</p>
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
22434000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
16811000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
18384000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2817000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4050000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1200000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1600000
CY2022 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2025-03-31
CY2022 mchx Payments For Lease Termination Fee
PaymentsForLeaseTerminationFee
671000
CY2022 mchx Contribution As Credit Against Lease Payments
ContributionAsCreditAgainstLeasePayments
180000
CY2019Q3 mchx Contribution From Lessor As Reimbursement Towards Leasehold Improvements
ContributionFromLessorAsReimbursementTowardsLeaseholdImprovements
180000
CY2018Q1 us-gaap Payments For Tenant Improvements
PaymentsForTenantImprovements
373000
CY2018Q2 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
575000
CY2019Q2 us-gaap Line Of Credit Facility Increase Decrease For Period Net
LineOfCreditFacilityIncreaseDecreaseForPeriodNet
100000
CY2022 mchx Lease Termination Month And Year
LeaseTerminationMonthAndYear
2023-03
CY2022 mchx Payments For Lease Termination Fee
PaymentsForLeaseTerminationFee
671000
CY2021 mchx Long Term Operating Lease Cost
LongTermOperatingLeaseCost
1862000
CY2022 mchx Long Term Operating Lease Cost
LongTermOperatingLeaseCost
1943000
CY2021 mchx Short Term Operating Lease Cost
ShortTermOperatingLeaseCost
8000
CY2022 mchx Short Term Operating Lease Cost
ShortTermOperatingLeaseCost
202000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
1870000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
2145000
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y10M24D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y2M12D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.048
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.046
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1696000
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
59000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1637000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1252000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
385000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1540000
CY2022Q4 us-gaap Other Commitment Due In Next Twelve Months
OtherCommitmentDueInNextTwelveMonths
2502000
CY2022Q4 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
4042000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
562000
CY2022Q4 us-gaap Other Commitment Due In Second Year
OtherCommitmentDueInSecondYear
196000
CY2022Q4 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
758000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
566000
CY2022Q4 us-gaap Other Commitment Due In Third Year
OtherCommitmentDueInThirdYear
0
CY2022Q4 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
566000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
400000
CY2022Q4 us-gaap Other Commitment Due In Fourth Year
OtherCommitmentDueInFourthYear
0
CY2022Q4 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
400000
CY2022Q4 mchx Lessee Operating Lease Liability Payments Due Year Five And Thereafter
LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndThereafter
380000
CY2022Q4 mchx Other Commitment Due In Fifth Year And Thereafter
OtherCommitmentDueInFifthYearAndThereafter
0
CY2022Q4 mchx Contractual Obligation Due In Fifth Year And Thereafter
ContractualObligationDueInFifthYearAndThereafter
380000
CY2022Q4 mchx Operating Lease Liability Payments Due
OperatingLeaseLiabilityPaymentsDue
3448000
CY2022Q4 us-gaap Other Commitment
OtherCommitment
2698000
CY2022Q4 us-gaap Contractual Obligation
ContractualObligation
6146000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-1173000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-7525000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-2985000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-536000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4158000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8061000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
204000
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
58000
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
39000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
20000
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
67000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
106000
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
20000
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-98000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
232000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
184000
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-873000
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1693000
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-448000
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
79000
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-747000
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-150000
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
-1000
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
16000
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
434000
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
190000
CY2021 mchx Income Tax Reconciliation Gain On Cares Act Loan
IncomeTaxReconciliationGainOnCARESActLoan
-1089000
CY2022 mchx Income Tax Reconciliation Gain On Cares Act Loan
IncomeTaxReconciliationGainOnCARESActLoan
32000
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
3334000
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1815000
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Impairment Losses
IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
98000
CY2021 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
544000
CY2022 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
237000
CY2021 us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
68000
CY2022 us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
132000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
232000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
184000
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
476000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
434000
CY2021Q4 mchx Deferred Tax Asset Intangible Assets
DeferredTaxAssetIntangibleAssets
5985000
CY2022Q4 mchx Deferred Tax Asset Intangible Assets
DeferredTaxAssetIntangibleAssets
3341000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2405000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
675000
CY2021Q4 mchx Deferred Tax Assets Operating And Capital Loss Carryforwards Domestic
DeferredTaxAssetsOperatingAndCapitalLossCarryforwardsDomestic
35052000
CY2022Q4 mchx Deferred Tax Assets Operating And Capital Loss Carryforwards Domestic
DeferredTaxAssetsOperatingAndCapitalLossCarryforwardsDomestic
35724000
CY2021Q4 mchx Deferred Tax Assets Operating And Capital Loss Carryforwards
DeferredTaxAssetsOperatingAndCapitalLossCarryforwards
3353000
CY2022Q4 mchx Deferred Tax Assets Operating And Capital Loss Carryforwards
DeferredTaxAssetsOperatingAndCapitalLossCarryforwards
5326000
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
5184000
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
5421000
CY2021Q4 mchx Deferred Tax Asset Lease Liability
DeferredTaxAssetLeaseLiability
866000
CY2022Q4 mchx Deferred Tax Asset Lease Liability
DeferredTaxAssetLeaseLiability
426000
CY2022Q4 mchx Deferred Tax Assets Capitalized Research And Development
DeferredTaxAssetsCapitalizedResearchAndDevelopment
1054000
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
547000
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
460000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
53868000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
52861000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
53066000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
51795000
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
802000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1066000
CY2021Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
393000
CY2022Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
1107000
CY2021Q4 mchx Deferred Tax Laibility Right Of Use Asset
DeferredTaxLaibilityRightOfUseAsset
595000
CY2022Q4 mchx Deferred Tax Laibility Right Of Use Asset
DeferredTaxLaibilityRightOfUseAsset
192000
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
186000
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
233000
CY2021 us-gaap Immaterial Error Correction
ImmaterialErrorCorrection
The net amount and impact are zero. We evaluated the materiality of the adjustment and concluded that its impact was not material on our financial statements taken as a whole and did not affect our balance sheet, statement of operations, stockholders’ equity or cash flows, for any periods presented.
CY2022Q4 mchx Deferred Tax Assets Capitalized Research And Development
DeferredTaxAssetsCapitalizedResearchAndDevelopment
1100000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
51800000
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
9800000
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
2200000
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2000
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.66
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
439000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
439000
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
3.69
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1365000
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
72000
CY2021 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
55000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1382000
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
2000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1384000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021 mchx Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Exercise Price Less Than Market Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePriceLessThanMarketValue
0
CY2022 mchx Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Exercise Price Less Than Market Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePriceLessThanMarketValue
0
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2674000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2646000
CY2021 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2022 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
16116000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3601000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.43
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
360000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
1262000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
739000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
739000
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.08
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
133000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
133000
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.14
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
16599000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3766000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.14
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
10000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2113000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.74
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
3000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.21
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.06
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
71000
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1900000
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3000
CY2021 us-gaap Other Postretirement Benefits Payments
OtherPostretirementBenefitsPayments
220000
CY2022 us-gaap Other Postretirement Benefits Payments
OtherPostretirementBenefitsPayments
205000
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Consideration
DisposalGroupIncludingDiscontinuedOperationConsideration
2300000
CY2022 mchx Support Services Fees
SupportServicesFees
6400000
CY2021 mchx Support Services Fees
SupportServicesFees
6600000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
26530000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
16857000
CY2021Q4 mchx Finite Lived Intangible Assets Impairment
FiniteLivedIntangibleAssetsImpairment
4959000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4714000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
26530000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
18981000
CY2022Q4 mchx Finite Lived Intangible Assets Impairment
FiniteLivedIntangibleAssetsImpairment
4959000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2590000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4500000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2100000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2000000.0
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
602000
CY2022 us-gaap Disposal Group Including Discontinued Operation Description And Timing Of Disposal
DisposalGroupIncludingDiscontinuedOperationDescriptionAndTimingOfDisposal
The Company received cash consideration at closing of approximately $2.3 million. No gain or loss on the sale of discontinued operations was recognized in the Consolidated Statement of Operations as it was sold to a related party. The net consideration received from the sale was recognized in the Company’s Consolidated Statements of Stockholder’s Equity. The sale also included (i) contingent consideration based on the achievement of certain revenue and thresholds from the Call Marketplace, Local Leads Platform and the purchaser’s total business; (ii) certain contingent sales transaction consideration; (iii) shares of Class B common stock in the purchaser equal to the issuance of a 10% equity interest; and (iv) the cancellation of Company stock options for 1.5 million shares currently held by two officers of the Company who were involved in the transaction
CY2021 mchx Reductions To Payroll Expenses Under Foreign Wage Subsidy
ReductionsToPayrollExpensesUnderForeignWageSubsidy
444000
CY2022 mchx Reductions To Payroll Expenses Under Foreign Wage Subsidy
ReductionsToPayrollExpensesUnderForeignWageSubsidy
10000
CY2021 us-gaap Interest And Other Income
InterestAndOtherIncome
3000
CY2022 us-gaap Interest And Other Income
InterestAndOtherIncome
99000
CY2021 us-gaap Interest Expense
InterestExpense
37000
CY2021 mchx Interest Income Expense Other
InterestIncomeExpenseOther
2487000
CY2022 mchx Interest Income Expense Other
InterestIncomeExpenseOther
-11000
CY2021 mchx Interest Income And Other Net
InterestIncomeAndOtherNet
2453000
CY2022 mchx Interest Income And Other Net
InterestIncomeAndOtherNet
88000
CY2022 dei Auditor Name
AuditorName
RSM US LLP
CY2022 dei Auditor Location
AuditorLocation
Seattle, WA
CY2022 dei Auditor Firm
AuditorFirmId
49

Files In Submission

Name View Source Status
mchx-20221231_cal.xml Edgar Link unprocessable
0001564590-23-005061-index-headers.html Edgar Link pending
0001564590-23-005061-index.html Edgar Link pending
0001564590-23-005061.txt Edgar Link pending
0001564590-23-005061-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gqb2kvy2bxnu000001.jpg Edgar Link pending
gqb2kvy2bxnu000002.jpg Edgar Link pending
gqb2kvy2bxnu000003.jpg Edgar Link pending
gqb2kvy2bxnu000004.jpg Edgar Link pending
gqb2kvy2bxnu000005.jpg Edgar Link pending
gqb2kvy2bxnu000006.jpg Edgar Link pending
gqb2kvy2bxnu000007.jpg Edgar Link pending
gqb2kvy2bxnu000008.jpg Edgar Link pending
gqb2kvy2bxnu000009.jpg Edgar Link pending
gqb2kvy2bxnu000010.jpg Edgar Link pending
gqb2kvy2bxnu000011.jpg Edgar Link pending
gqb2kvy2bxnu000012.jpg Edgar Link pending
gqb2kvy2bxnu000013.jpg Edgar Link pending
gqb2kvy2bxnu000014.jpg Edgar Link pending
gqb2kvy2bxnu000015.jpg Edgar Link pending
gqb2kvy2bxnu000016.jpg Edgar Link pending
gqb2kvy2bxnu000017.jpg Edgar Link pending
gqb2kvy2bxnu000018.jpg Edgar Link pending
gqb2kvy2bxnu000019.jpg Edgar Link pending
gqb2kvy2bxnu000020.jpg Edgar Link pending
gqb2kvy2bxnu000021.jpg Edgar Link pending
gqb2kvy2bxnu000022.jpg Edgar Link pending
gqb2kvy2bxnu000023.jpg Edgar Link pending
gqb2kvy2bxnu000024.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
gqb2kvy2bxnu000025.jpg Edgar Link pending
gqb2kvy2bxnu000026.jpg Edgar Link pending
gqb2kvy2bxnu000027.jpg Edgar Link pending
gqb2kvy2bxnu000028.jpg Edgar Link pending
mchx-10k_20221231.htm Edgar Link pending
mchx-20221231.xsd Edgar Link pending
mchx-ex1025_138.htm Edgar Link pending
mchx-ex211_12.htm Edgar Link pending
mchx-ex231_8.htm Edgar Link pending
mchx-ex232_651.htm Edgar Link pending
mchx-ex31ii_93.htm Edgar Link pending
mchx-ex31i_11.htm Edgar Link pending
mchx-ex32_13.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
mchx-20221231_def.xml Edgar Link unprocessable
mchx-20221231_lab.xml Edgar Link unprocessable
mchx-20221231_pre.xml Edgar Link unprocessable
mchx-10k_20221231_htm.xml Edgar Link completed
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending